SEER Q4 2021 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+802.4% YoY

Gross Profit

-$442,000-14.6% margin

Operating Income

-$20M-656.6% margin

Net Income

-$20M-651.0% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+41.4%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$14M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$539M

Total Liabilities

$36M

Stockholders' Equity

$503M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$336,000	+802.4%
Gross Profit	-$442,000	-$138,000	-220.3%
Operating Income	-$20M	-$13M	-52.7%
Net Income	-$20M	-$13M	-52.6%

Revenue Segments

Product

$2M61%

Related Party

$1M38%

Grant

$34,0001%